BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 1st Quarter - Termination

NOVO NORDISK, INC.

via CHRISTIE 55 SOLUTIONS LLC

1st Quarter (Jan 1 - Mar 31) · 2021Posted Apr 19, 2021Filing document ↗LDA record ↗

Income$40Kfee reported

Client

Name: NOVO NORDISK, INC.
Description: Biopharmaceutical
Location: New Jersey · United States of America

Registrant

Firm: CHRISTIE 55 SOLUTIONS LLC
Description: Public Affairs Firm
Location: Morristown, New Jersey, United States of America

Lobbying activities

1 issue

Medicare/Medicaid
Regulation with respect to coverage of drug categories in Medicare Part D.
LobbyistsRICHARD BAGGER · CHRISTOPHER CHRISTIE
TargetedHealth & Human Services, Dept of (HHS)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

NOVO NORDISK, INC. — Lobbying — Receipts Report